St. Joseph's Hospital and Medical Center

Summary

St. Joseph's Hospital and Medical Center is a medical facility located in Phoenix, Arizona. This center is recognized for care of Brain Tumor, Ovarian Cancer, Glioblastoma, Fallopian Tube Cancer, Stroke and other specialties. St. Joseph's Hospital and Medical Center is involved with conducting 210 clinical trials across 338 conditions. There are 21 research doctors associated with this hospital, such as Nader Sanai, MD, Rajat Walia, MD, Ekokobe Fonkem, MD, and Justin Reynolds.

Top PIs

Clinical Trials running at St. Joseph's Hospital and Medical Center

Brain Tumor

Glioblastoma

Cancer

Heart Failure

Alpha-1 Antitrypsin Deficiency

Meningioma

Lung Cancer

Parkinson's Disease

Emphysema

Stroke

Focused Ultrasound + Immunotherapy

for Brain Cancer

The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.

Recruiting

3 awards

Phase 3

Radiation Therapy vs Observation

for Meningioma

This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.

Recruiting

2 awards

Phase 3

12 criteria

Temsirolimus Infusion

for Brain Tumor

This is a single-center, open-label, dose-escalating Phase 0 trial that will enroll participants with a confirmed diagnosed recurrent high-grade glioma (grade 3 or 4 per WHO criteria) targeting the mTOR pathway. Eligible participants will be administered a single infusion of temsirolimus through super-selective intra-arterial infusion or intravenous infusion. Participants will receive the study drug administration on the same day as the planned surgical resection of the tumor.

Recruiting

1 award

Phase < 1